论文部分内容阅读
目的观察醒脑静治疗肺性脑病的疗效。方法 60例肺性脑病患者随机分为治疗组和对照组各30例,两组均采用吸氧、抗感染、舒张支气管、纠正酸碱平衡失调及电解质紊乱、营养支持,必要时机械通气等治疗。治疗组加用醒脑静20～40ml静脉滴注,每日1次,疗程5～10d。结果治疗组总有效率86.87%,对照组总有效率46.67%,治疗组明显高于对照组(P<0.05)。结论常规治疗方法上加用醒脑静,有促醒、退热功能,且安全有效。醒脑静不失为临床抢救的一线用药。
Objective To observe the effect of xingnaojing on pulmonary encephalopathy. Methods Sixty patients with pulmonary encephalopathy were randomly divided into treatment group (n = 30) and control group (n = 30). Oxygen inhalation, anti-infective, bronchial relaxation were used in both groups to correct acid-base balance disorders and electrolyte imbalance, nutritional support, . The treatment group was given Xinjing intravenous infusion of 20 ~ 40ml, 1 day, treatment of 5 ~ 10d. Results The total effective rate was 86.87% in the treatment group and 46.67% in the control group, which was significantly higher in the treatment group than in the control group (P <0.05). Conclusion The conventional treatment plus Xingnaojing, a wake-up, antipyretic function, and safe and effective. Xingjingjing after all, a first-line treatment for clinical treatment.